ÉèΪÊ×Ò³ ¼ÓÈëÊÕ²Ø

TOP

Vancomycin powder 10vials¡Á0.5g£¨ÑÎËáÍò¹ÅùËØ×¢Éä·ÛÄ©£¬‰cËá¥Ð¥ó¥³¥Þ¥¤¥·¥óÉ¢£©
Ò©µê¹ú±ð£º  
²úµØ¹ú¼Ò£º ÈÕ±¾ 
´¦ ·½ Ò©£º ÊÇ 
ËùÊôÀà±ð£º 0.5¿Ë/Æ¿ 10Æ¿/ºÐ 
°ü×°¹æ¸ñ£º 0.5¿Ë/Æ¿ 10Æ¿/ºÐ 
¼Æ¼Ûµ¥Î»£º ºÐ 
Éú²ú³§¼ÒÖÐÎIJο¼ÒëÃû:
Ã÷ÖÎÖÆ»¯ÖÆÒ©
Éú²ú³§¼ÒÓ¢ÎÄÃû:
Meiji Seika Pharma Co.Ltd.
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·1:
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·2:
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·3:
Ô­²úµØÓ¢ÎÄÉÌÆ·Ãû:
Vancomycin£¨‰cËá¥Ð¥ó¥³¥Þ¥¤¥·¥óÉ¢£©0.5g/vials 10vials/box
Ô­²úµØÓ¢ÎÄÒ©Æ·Ãû:
Vancomycin Hydrochloride
ÖÐÎIJο¼ÉÌÆ·ÒëÃû:
Vancomycin£¨‰cËá¥Ð¥ó¥³¥Þ¥¤¥·¥óÉ¢£©0.5¿Ë/Æ¿ 10Æ¿/ºÐ
ÖÐÎIJο¼Ò©Æ·ÒëÃû:
ÑÎËáÍò¹ÅùËØ
ÔøÓÃÃû:
¼ò½é£º

 

²¿·ÝÖÐÎÄÑÎËáÍò¹ÅùËØ´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£©
Ó¢ÎÄÃû£ºVancomycin Hydrochloride
ÉÌÆ·Ãû£ºVancomycin powder
ÖÐÎÄÃû£ºÑÎËáÍò¹ÅùËØ·Û
Éú²úÉÌ£ºÃ÷ÖÎÖÆ»¯ÖÆÒ©
Ò©Æ·¼ò½é
Íò¹ÅùËØ£¨Vancomycin ‰cËá¥Ð¥ó¥³¥Þ¥¤¥·¥óÉ¢£©ÊÇÒ»ÖÖÌÇëÄÀ࿹ÉúËØ£¬ÓÃÓÚÖÎÁÆϸ¾ú¸ÐȾ¡£
ҩЧ·ÖÀàÃû³Æ
ÌÇëÄ¿¹ÉúËØÖƼÁ
Åú×¼ÈÕÆÚ£º2008Äê4ÔÂ
É̘ËÃû
Vancomycin
ÐÔ×´
ÑÎËáÍò¹ÅùËØΪ°×É«·ÛÄ©¡£
¸Ã²úÆ·Ò×ÈÜÓÚË®£¬Î¢ÈÜÓÚ¼×õ£°·£¬Î¢ÈÜÓÚ¼×´¼£¬¼«Î¢ÈÜÓÚÒÒ´¼£¨95£©£¬¼¸ºõ²»ÈÜÓÚÒÒëæ¡£
±¾²úÆ·¾ßÓÐÎüʪÐÔ¡£
Ò»°ãÃû
¥Ð¥ó¥³¥Þ¥¤¥·¥ó‰cËá‰c¡¡Vancomycin Hydrochloride
ÂÔ¡¡ºÅ
VCM
»¯Ñ§Ãû
£¨1S,2R,18R,19R,22S,25R,28R,40S£©-50-£Û3-Amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl-£¨1→2£©-β-D-glucopyranosyloxy£Ý-22-carbamoylmethyl-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-£Û£¨2R£©-4-methyl-2-£¨methylamino£©pentanoylamino£Ý-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo£Û26.14.2.23,6.214,17.18,12.129,33.010,25.034,39£Ýpentaconta-3,5,8,10,12£¨50£©,14,16,29,31,33£¨49£©,34,36,38,45,47-pentadecaene-40-carboxylic acid monohydrochloride
·Ö×Óʽ
C66H75Cl2N9O24・HCl
·Ö×ÓÁ¿
1485.71
˜‹Ôìʽ
ÈÚµã
ûÓÐÃ÷È·µÄÈ۵㡣
£¨ÔÚ 120°C»ò¸ü¸ßʱ»áÖð½¥×ÅÉ«ºÍ·Ö½â£©
ÉóÅúÌõ¼þ
¿¼Âǵ½Ê¹ÓõÄÉèÊ©¡¢ÉèÊ©µÄÌáÈ¡ÂʺÍÉèÊ©µÄÊýÁ¿£¬²ÉÈ¡ÒÔÏ´ëÊ©¡£
1. ¼ÌÐø½øÐÐÊʵ±µÄÉÏÊкó¼à²â£¨°üÀ¨Ãô¸ÐÐÔµ÷²é£©²¢ÊÕ¼¯ÐÅÏ¢¡£
2. ¼ÌÐøÏòÒ½ÁÆ»ú¹¹Ìṩ±ØÒªµÄÐÅÏ¢£¬ÒÔ·ÖÎöÊÕ¼¯µ½µÄÐÅÏ¢²¢È·±£ÕýȷʹÓá£
3. ÿÄêÒ»´ÎÏòºñÉúÀͶ¯Ê¡Ìá½»»ùÓÚ¶¨ÆÚ°²È«±¨¸æµÄ±¨¸æ¡£
ҩЧҩÀí
×÷ÓûúÖÆ
1.¿¹¾ú×÷ÓÃ
£¨1£©Íò¹ÅùËØÔÚÌåÍâ¶ÔÆÏÌÑÇò¾ú¡¢Á´Çò¾ú¡¢·ÎÑ×Çò¾ú¡¢³¦Çò¾ú¡¢Ëó×´Ñ¿æ߸˾ú£¨°üÀ¨Ëó×´Ñ¿æ߸˾úºÍ¼èÄÑËó¾ú£©¡¢·ÅÏß¾úºÍÈéËá¸Ë¾ú¾ßÓп¹¾ú»îÐÔ¡£ Ëü¶Ô¸ïÀ¼ÊÏÒõÐÔ¾úûÓп¹¾ú»îÐÔ¡£
(2)Íò¹ÅùËØÔÚÌåÍâ¶ÔÄͼ×ÑõÎ÷ÁÖ½ð»ÆÉ«ÆÏÌÑÇò¾ú(MRSA)Óп¹¾ú»îÐÔ£¬ÓëÆäËû¿¹¾úÒ©ÎïÎÞ½»²æÄÍÒ©ÐÔ¡£´ËÍ⣬ÔÚʹÓÃMRSAµÄÌåÍâ´«´úÅàÑøÊÔÑéÖУ¬¶ÔÍò¹ÅùËصĿ¹ÐԽϵ͡£
2.×÷ÓûúÖÆ
Íò¹ÅùËصÄ×÷ÓÃÊÇÓÉÓÚÒÖÖÆϸ¾úϸ°û±ÚºÏ³É£¬Æ俹¾ú×÷ÓÃÊÇɱ¾ú×÷Óá£Ëü»¹¸Ä±äÁËϸ¾úϸ°ûĤµÄͨ͸ÐÔ¡£
ÊÊÓ¦Ö¢
1¡¢´«È¾ÐÔ³¦Ñ×
<ÊÊÓþúÖÖ>
Äͼ×ÑõÎ÷ÁÖ½ð»ÆÉ«ÆÏÌÑÇò¾ú(MRSA)¡¢¼èÄÑËó¾ú¡¢¶ÔÍò¹ÅùËØÃô¸Ð
<ÊÊÓ¦Ö¢>
¸ÐȾÐÔ³¦Ñ×£¨°üÀ¨Î±Ä¤ÐԽ᳦Ñ×£©
2. ¹ÇËèÒÆֲʱµÄ³¦Î¸¾øÓý
Ó÷¨ÓëÓÃÁ¿
1.¸ÐȾÐÔ³¦Ñ×£¨°üÀ¨Î±Ä¤ÐԽ᳦Ñ×£©
ʹÓÃʱÈܽ⣬³ÉÈ˳£ÓüÁÁ¿Îª0.125¡«0.5g£¨µÎ¶È£©¿Ú·þ£¬Ò»ÈÕ4´Î¡£
¿É¸ù¾Ý»¼ÕßµÄÄêÁä¡¢ÌåÖغÍÖ¢×´µ÷Õû¼ÁÁ¿¡£
2. ¹ÇËèÒÆֲʱµÄ³¦Î¸¾øÓý
ʹÓÃʱÈܽ⣬һ°ã³ÉÈËÒ»´Î0.5g£¨µÎ¶È£©¿Ú·þ£¬Ò»ÈÕ4¡«6´Î£¬Óë·ÇÎüÊÕÐÔ¿¹¾ú¼Á¡¢¿¹Õæ¾ú¼ÁºÏÓá£
¿É¸ù¾Ý»¼ÕßµÄÄêÁä¡¢ÌåÖغÍÖ¢×´µ÷Õû¼ÁÁ¿¡£
°ü×°
10Æ¿ µ¥¼Û£º2637Ôª/ÈËÃñ±Ò ¶þºÐÆð¶©
ÖÆÔìÉ̺ͷÖÏúÉÌ
´óÊiÖÆÒ©Öêʽ»áÉç
ÏúÊÛ
Ã÷ÖÎÖÆ»¯ÖÆÒ©Öêʽ»áÉç
×¢£ºÒÔÉÏÖÐÎÄ´¦·½×ÊÁϲ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ­´¦·½×ÊÁÏΪ׼¡£
ÍêÕû˵Ã÷×ÊÁϸ½¼þ£º
https://www.info.pmda.go.jp/go/pack/6113001B1143_1_01/

¡¾´ó ÖРС¡¿¡¾´òÓ¡¡¿ ¡¾·±Ìå¡¿¡¾Í¶¸å¡¿¡¾Êղء¿ ¡¾ÍƼö¡¿¡¾¾Ù±¨¡¿¡¾ÆÀÂÛ¡¿ ¡¾¹Ø±Õ¡¿ ¡¾·µ»Ø¶¥²¿¡¿
·ÖÏíµ½QQ¿Õ¼ä
·ÖÏíµ½: 
ÉÏһƪ£ºLinezolid I.V.Infusion 5bag¡Á60.. ÏÂһƪ£ºE.E.S. Granules For Oral Suspen..

Ïà¹ØÀ¸Ä¿

×îÐÂÎÄÕÂ

ͼƬÖ÷Ìâ

ÈÈÃÅÎÄÕÂ

ÍƼöÎÄÕÂ